Kedrion S.p.a.

This study is testing two different doses of an immune globulin (antibody) therapy given through an IV to see which works better for maintaining control of CIDP, a chronic nerve disorder. About 161 adults with CIDP who currently depend on treatment will receive either a lower or …

This study is testing whether a medication called Coagadex can safely and effectively stop or prevent bleeding in adults with a rare clotting problem caused by light chain amyloidosis. The medication provides concentrated clotting factor to help blood clot properly. Researchers w…

This study is testing the effectiveness and safety of an intravenous immunoglobulin (IVIg) treatment for adults with chronic immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, increasing the risk of bleeding. The main goal is to see if the treat…